Bubs Australia (ASX:BUB)
ASX announcement history & article coverage
Transparent by design.
Announcments by Bubs Australia (ASX:BUB) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Response to ASX 3Y Query
Bubs Australia explains late director interest notice as administrative oversight
Change of Director's Interest Notice - JC
Annual General Meeting - Notice of Access
Notice of Annual General Meeting/Proxy Form
Notification regarding unquoted securities - BUB
Annual Report
Bubs delivers revenue and underlying EBITDA growth but reports $4.6m loss and going concern uncertainty
Cleansing Notice
Application for quotation of securities - BUB
Change of Director's Interest Notice - PJ
Date of AGM and Closing Date for Director Nominations
Change of Director's Interest Notice - LTM
Response to ASX Aware Query
Bubs confirms FDA approval information was price-sensitive and says disclosure was prompt
FDA Approval Webinar Presentation
Bubs secures permanent FDA authorisation for three infant formula products
FDA Approval Webinar Notification
Bubs Australia schedules webinar on permanent FDA authorisation
Bubs Secures Permanent US FDA Approval for Infant Formula
Trading Halt
Pause in Trading
Change of Director's Interest Notice - LTM
Change of Director's Interest Notice - PDP
Change of Director's Interest Notice - PJ
FY26 Appendix 4G and Corporate Governance Statement
FY26 Results Presentation
Bubs Australia FY26 revenue grows 9% with strong USA sales; underlying EBITDA rises to AUD 5.3 million
FY26 Results
Bubs delivers FY26 revenue growth and invests for future expansion
FY26 Appendix 4E and Preliminary Annual Report
Bubs Australia reports FY26 revenue growth but posts $4.6 million loss amid FDA approval uncertainty
FY26 Results Announcement Date and Webcast Notification
Quarterly Activities/Appendix 4C Cash Flow Report
Bubs Australia Q4 FY26 revenue up 11%, liquidity strong at $19.4 million